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 Letter to the Editor 
 162 insomnia patients participated in this programme between 
2009 and 2012 in groups of 7–8 persons. Its evaluation was ap-
proved by the Ethical Committee of the University of Regensburg, 
and all patients signed the informed consent forms. Before treat-
ment, the patients were interviewed and examined by a sleep ex-
pert regarding the following inclusion criteria: (1) diagnostic cri-
teria of primary insomnia for at least 1 year according to the Inter-
national Classification of Sleep Disorders 2  [7] ; (2) evidence of 
conditioned sleep difficulty and/or heightened arousal in bed, and 
(3) previous participation in an outpatient CBT-I without success 
or inability to participate in standard outpatient CBT-I because of 
disease severity or inability to reduce hypnotics. Exclusion criteria 
were: (1) untreated organic sleep disorder; (2) severe psychiatric 
disorders, and (3) inability to participate in a group therapy for any 
reason. Thirty-one participating patients had to be excluded from 
the analysis for the following reasons: 4 patients quit the therapy, 
in 5 patients available data were incomplete and in 22 patients the 
presence of exclusion criteria (14 with sleep apnoea syndrome, 8 
with severe psychiatric disorder) became only apparent during 
treatment. The remaining 131 patients [mean age 53.6 ± 12.2 years; 
110 women; mean Pittsburgh Sleep Quality Index (PSQI) 14.1 ± 
3.1] were included in the analysis. The objective measurement of 
sleep was performed by PSG at the beginning and end of treatment. 
Subjective insomnia symptoms were quantified at baseline and 6 
months after treatment using the PSQI and the Regensburg In-
somnia Scale (RIS  [8] : a 10-item questionnaire which measures 
psychological aspects of insomnia over a period of 4 weeks; total 
range 0–40 points; cut-off for insomnia 12 points) and analysed 
using paired t tests. Depressive symptoms were assessed by the 
Beck Depression Inventory. Both PSG data and clinical ratings 
were compared with paired t tests.
 Acceptance of the programme by patients was good; only 4 per-
sons quit the therapy prematurely. All 78 patients on a sedative-
hypnotic regimen before treatment stopped their medication dur-
ing the therapy. After treatment, time in bed (436.5 ± 35.8 vs. 381.8 
± 44.6 min; t = 11.786; p < 0.0005), sleep latency (15.8 ± 18.4 vs. 8.1 
± 10.7 min; t = 11.786; p < 0.0005) and wake time after sleep onset 
(72.9 ± 48.3 vs. 49.8 ± 37.5 min) significantly decreased whereas 
sleep efficiency (77.2 ± 48.3 vs. 82.3 ± 13.0%; t = –4.002; p < 0.0005) 
increased. Total sleep time was shortened (337.9 ± 60.0 vs. 322.3 ± 
81.8 min; t = 2.025; p = 0.045). Clinical ratings at 6 months were 
available for 97 patients with a significant improvement in the 
PSQI, the RIS (24.5 ± 5.4 vs. 19.0 ± 6.8; t = 11.281; p < 0.0005) and 
the Beck Depression Inventory. The improvement was most pro-
nounced in RIS items ‘sleep related thinking’ and ‘hypnotic intake’. 
However, in spite of the significant improvements, the mean level 
of insomnia was still moderate to severe. There was no control 
group, but repeated baseline assessments of insomnia symptoms 
were performed with an interval of 4–5 months (RIS 0: 24.7 ± 5.7, 
 Cognitive-behavioural therapy for insomnia (CBT-I) is an ef-
fective treatment, covering a wide spectrum of therapy strategies, 
ranging from computerized forms  [1] to standardized outpatient 
group settings  [2, 3] . However, nearly one fifth of all patients fail 
to benefit from CBT-I programmes  [4] , presumably partly due to 
limitations inherent in the outpatient setting, e.g. problems with 
implementing CBT-I modules into the patient’s daily home 
schedule. Moreover, disease severity (e.g. hopelessness or anxi-
ety) or difficulties in quitting the intake of hypnotics may impede 
participation. To address these limitations, we have developed an 
intensified CBT-I programme for an inpatient setting lasting 14 
days. This programme was intended to (1) improve diagnostic 
evaluation by using polysomnography (PSG), (2) offer a more 
intense treatment approach by combining single and group ses-
sions, (3) relieve patients from their daily routines and responsi-
bilities, (4) ensure better monitoring of proper application of 
therapy elements and (5) handle potential complications when 
tapering off hypnotics. In the development of this programme, 
special emphasis was put on a short duration for socio-economic 
reasons, feasibility and economic use of therapeutic resources.
 The programme comprises a fixed schedule of bedtimes and 
classical modules of CBT-I such as stimulus control  [5] , psycho-
educational elements and relaxation therapy. The fixed schedule 
of bedtimes is a variation of the classical bedtime restriction  [6] : 
patients had a fixed time window of 6 h (for example midnight to 
6 a.m.) in which they were allowed to sleep only. Patients were 
closely surveyed and coached in the daily implementation of these 
elements throughout their hospital stay and they were regularly 
seen by a psychiatrist and a sleep expert. Two nights of PSG (ad-
aptation and baseline) were performed at the beginning and one at 
the end of the programme. After each night, the patients were in-
formed individually about the sleep parameters measured in a sin-
gle session. All patients slept in a 2-person bedroom on the ward, 
except for the PSG nights in the sleep laboratory. 
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RIS I: 24.9 ± 5.7) in some of the patients (n = 34). A repeated t test 
revealed no significant difference between the RIS scores on the 
two baseline measurements indicating symptom stability before 
treatment. Six months after therapy there was a significant reduc-
tion of the RIS score in this subsample (RIS II: 18.7 ± 6.2; t = 7.930; 
p < 0.0005). Thus, spontaneous fluctuations are unlikely to explain 
the improvement observed after treatment. However, because of 
the open study design, potential interference by some unspecified 
outside influence cannot be excluded.
 Nevertheless, the low treatment drop-out rate (3%), together 
with the favourable results, demonstrate the feasibility and thera-
peutic potential of an inpatient CBT-I programme. Whether the 
higher costs of the inpatient CBT-I programme exceed the reduc-
tion of socio-economic costs of insomnia should be investigated 
by a cost-effectiveness study. PSG has been shown to be a valuable 
tool for revising disturbed sleep perception and for measuring the 
changes of sleep after therapy. The close medical supervision made 
it easier for patients to quit their hypnotics. Pending confirmation 
by controlled trials, inpatient CBT-I could become an important 
option in the stepped-care management of insomnia described by 
Espie  [9] .
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